Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities
Health CareMedical Equipment and Services
  • Price (USD)245.66
  • Today's Change3.34 / 1.38%
  • Shares traded4.95m
  • 1 Year change+27.93%
  • Beta0.8470
Data delayed at least 15 minutes, as of Oct 31 2024 23:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

  • Revenue in USD (TTM)23.74bn
  • Net income in USD3.93bn
  • Incorporated1986
  • Employees61.00k
  • Location
    Danaher Corp2200 Pennsylvania Ave NW Ste 800WWASHINGTON 20037-1731United StatesUSA
  • Phone+1 (202) 828-0850
  • Fax+1 (202) 828-0860
  • Websitehttps://www.danaher.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medtronic PLC32.58bn3.93bn116.06bn95.00k30.442.4217.613.562.972.9724.6637.390.36092.035.51342,915.804.384.574.925.1465.5366.7512.1413.491.6112.100.366580.583.641.16-2.18-4.566.956.65
Boston Scientific Corporation15.91bn1.79bn123.69bn48.00k69.43--42.347.771.211.2110.73--------331,458.30--2.50--2.9169.0168.8411.246.47--6.06--0.0012.297.71144.55-0.42767.82--
Stryker Corp21.97bn3.59bn138.47bn52.00k38.966.8829.936.309.339.3357.0852.860.53681.566.27422,576.908.776.6010.767.8463.8863.9916.3413.131.22--0.434543.7011.118.5534.229.680.104710.16
Danaher Corp23.74bn3.93bn175.02bn61.00k45.733.4128.307.375.305.2432.0571.030.28213.396.11389,213.104.675.935.196.5659.2658.7916.5719.111.0121.310.254614.33-10.336.98-32.5011.8516.1011.32
Intuitive Surgical, Inc.7.87bn2.24bn182.99bn13.68k82.5911.7466.3523.266.226.2221.8143.750.48481.987.44575,234.0013.9312.4215.6313.8366.9867.6028.7326.313.42--0.000.0014.4913.8535.989.7741.53--
Abbott Laboratories41.22bn5.77bn199.13bn114.00k34.70--22.994.833.303.3023.57--------361,552.60--7.72--9.3955.7156.7313.9914.39--28.32--54.95-8.125.58-17.4518.369.5712.74
Thermo Fisher Scientific Inc42.37bn6.14bn210.33bn122.00k34.534.2922.374.9615.9515.95110.12128.200.42924.624.68347,295.106.287.797.369.1140.9844.9414.6216.761.2624.400.41836.75-4.5811.96-13.7414.4314.3015.39
Data as of Oct 31 2024. Currency figures normalised to Danaher Corp's reporting currency: US Dollar USD

Institutional shareholders

30.62%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 202457.61m7.98%
BlackRock Fund Advisorsas of 30 Jun 202429.52m4.09%
SSgA Funds Management, Inc.as of 30 Jun 202427.67m3.83%
Wellington Management Co. LLPas of 30 Jun 202423.49m3.25%
T. Rowe Price Associates, Inc. (IM)as of 30 Jun 202418.45m2.55%
Capital Research & Management Co. (International Investors)as of 30 Jun 202417.53m2.43%
Fidelity Management & Research Co. LLCas of 30 Jun 202416.56m2.29%
Geode Capital Management LLCas of 30 Jun 202413.18m1.83%
Norges Bank Investment Managementas of 30 Jun 20249.17m1.27%
T. Rowe Price Investment Management, Inc.as of 30 Jun 20247.94m1.10%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.